Albumin management after liver transplantation

L Zhang,DR Xiu
DOI: https://doi.org/10.3321/j.issn:1673-8225.2007.43.006
2007-01-01
Abstract:AIM: Hypoalbuminemia is the common complication and the key factor of prognosis after liver transplantation. Reasonable usage of albumin is beneficial to short-term and long-term curative effect in liver transplantation patients. METHODS: Eighty patients, who had received liver transplantation and follow-up was over 6 months from October 2000 to June 2005 at Third Hospital, Peking University, were enrolled. All patients signed the informed consent. Albuminous administration after liver transplantation was changed since August 2003. ①Fifty patients in the high-dose albumin group were treated routinely with a great quantity of albumin more than 60 g per day early after liver transplantation. ②Thirty patients in the low-dose albumin group received rationally 0-20 g per day albumin. General condition, usage of albumin, prognosis and costs of patients in both groups were collected and analyzed. Patients with hypoalbuminemia-related severe complications in both groups were analyzed. RESULTS: Totally 80 patients were involved in the result analysis. ①There were no significant differences between two groups for the general information before and during the operation (P > 0.05). ②The albumin level and cost of albumin/hospitalization cost were significantly lower in the low-dose albumin group than the high-dose albumin group (P < 0.01). Liver function, albumin level, incidence of early complication, early mobidity, half-year survival rate and timing of breathing machine did not show significant difference at day 3 after transplantation between the two groups (P > 0.05). ③Liver function, albumin level, early mobidity, half-year survival rate and timing of breathing machine did not show significant difference at day 3 after transplantation in patients with hypoalbuminemia-related severe complications in both groups (P > 0.05). CONCLUSION: Excessive albumin management after liver transplantation did not improve the outcomes of liver transplantation patients. Reducing the routine albumin dosage and rising albumin dosage based on the plasma albumin level and complications were safe and reasonable for liver transplantation patients.
What problem does this paper attempt to address?